[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ocul
Ocular Therapeutix ($OCUL) sees positive analyst ratings and target price increases, but buyout rumors and market volatility persist. Recent insider selling has also been reported.
About $ocul
Ocular Therapeutix ($OCUL) is a biotechnology company.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-05-02
1-Year Low: XXX on 2025-09-28
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XXXX%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-09-14
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $ocul in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX +26%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-09-14
The most influential creators that mention $ocul in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BalaBioResearch | X | XXXXX | X | XXX |
| @MarketCap_Live | X | XXX | X | XXX |
| @Quantumup1 | X | XXXXX | X | XXX |
| @semodough | X | XXXXXX | XX | XXX |
| @zipjet | X | XXXXX | XX | XXX |
| @RazBioTech | X | XXX | X | XXX |
| @AscendingBio | X | XXX | X | XX |
| @unemon1 | X | XXXXXX | X | XX |
| @Biomaven | X | XXXXX | X | XX |
| @seedy19tron | XX | XXXXX | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +8%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-06-24
Most Supportive Themes
- Analyst Upgrades and Optimism: (35%) Positive analyst ratings and target price increases are driving enthusiasm.
- Potential for High Revenue: (20%) Discussions around the potential for significant future revenue based on market size and drug potential.
Most Critical Themes
- Buyout Concerns: (30%) Discussions around potential buyouts and insider activity.
- Market Volatility: (15%) Concerns about price fluctuations.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXX | XX% | XXX | XX% |
| Total | XXXXX | XX% | XXX | XX% | XXX | XX% |
Top assets mentioned In the posts about $ocul in the last XX hours
Advanced Micro Devices (AMD) Piper Sandler Companies (PIPR) Bitcoin Incognito (XBI) Critical Metals Corp. Ordinary Shares (CRML) Diginex Limited Ordinary Shares (DGNX) Apogee Therapeutics, Inc. Common Stock (APGE) USA Rare Earth, Inc. Class A Common Stock (USAR) Intellia Therapeutics, Inc (NTLA) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Avidity Biosciences, Inc. Common Stock (RNA)
Top topics mentioned In the posts about $ocul in the last XX hours
stocks technology, investment, stocks, advanced micro devices, stocks healthcare, $475m, $pipr, $sndx, stocks bitcoin treasuries, money, $xbi, dough, discount, $8b, $crml, $dgnx, $apge, $eypt, stocks industrials, stocks real estate, $oculs, $usar, $rvph, $aisp, $ntla, $rxrx, approved, $rna, regeneron pharmaceuticals inc, market cap, stocks consumer cyclical, $rytm, $lqda, $bpmc, $220b, spa, $56b, where is, $114k, $bp, $colb, $unp, alexandria real estate equities inc, screener, ticker, atm, $dhr, agilent technologies inc, $pen, showcase, billions, $cenx, $ag, brad, $uamy, $shop, $sndk, klarna, $klar, 6 months, rescue, protocol, $200m2b, $asst, $cdro, people with, give me, $axsm, $nuvl, $mrus, $regn, $15share, payout, $4503t, northrop grumman corp, stocks defense, $noc, $nvst, $100m, swift, $lrmr, dyne therapeutics, $gral, tesla, $incy, $mrna, acquisition, speculation, aligned, $12b, made in, let me, bold, sol, china, has been, $nari, $myov, $imgn, $krtx
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$OCUL Catalyst Date - 2025-10-16 Drug - AXPAXLI (OTX-TKI) Treatment - wet age-related macular degeneration (wet AMD)"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1116 followers, XX engagements
"@JeremyFalmouth @BalaBioResearch its not worth the premium you have in $OCUL currently. And lol how will the debate end both products have the place in the market. Owning this after recent raise is nonsensical at least to me and I bought around $X this year out at $XXXXX they think too much of themselves"
X Link @biotechsanya2 2025-10-14T22:11Z XXX followers, XXX engagements
"Midcaps ($2-20B) - Oct XX Gainers Losers $CRML +26% $DGNX -XXX% $NVTS +26% $VIST -XXX% $FLNC +17% $WSO.B -XXX% $DBRG +16% $INOD -XXX% $OUST +14% $SKE -XXX% $LUNR +14% $GGAL -X% $ORLA +14% $RYN -XXX% $PII +14% $TKC -XXX% $ACI +12% $PAM -XXX% $PCT +12% $OCUL -XXX% $WULF +10% $BMNR -XXX% $DLO +10% $PONY -XXX% $MARA +10% $TGS -XXX% $POWI +10% $ZLAB -XXX% $UUUU +9.8% $RBRK -5.5%"
X Link @MarketCap_Live 2025-10-14T19:48Z XXX followers, XXX engagements
"$OCUL is very interesting at this valuation even if you think SOL-1 has a XX% POS. Imagine the amount of people with wet AMD who just ask their doctor: "give me whatever has the least IVI's but still works." Easily a multi billion dollar drug if approved"
X Link @BalaBioResearch 2025-10-12T03:25Z 1026 followers, 2053 engagements